Recursive Partitioning Analysis Groups II–III Brain Metastases of Non-small Cell Lung Cancer: A Phase II Randomized Study Comparing Two Concurrent Chemoradiotherapy Regimens

Jena, 2008, Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom, J Thorac Oncol, 3, 140, 10.1097/JTO.0b013e318161d775 Jacot, 2001, Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors, Br J Cancer, 84, 903, 10.1054/bjoc.2000.1706 Lagerwaard, 1999, Identification of prognostic factors in patients with brain metastases: a review of 1292 patients, Int J Radiat Oncol Biol Phys, 43, 795, 10.1016/S0360-3016(98)00442-8 Posner, 1992, Management of brain metastases, Rev Neurol, 148, 477 Ushio, 1991, Chemotherapy of brain metastases from lung cancer carcinoma: a controlled randomized study, Neurosurgery, 28, 201, 10.1227/00006123-199102000-00005 Latz, 1998, Combined effects of ionizing radiation and 4-hydroperoxyifosfamide in vitro, Radiother Oncol, 46, 279, 10.1016/S0167-8140(97)00194-1 Quantin, 1997, Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer, Ann Oncol, 8, 911, 10.1023/A:1008217731021 Quantin, 1999, Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer, Lung Cancer, 26, 35, 10.1016/S0169-5002(99)00071-9 Gaspar, 1997, Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, 37, 745, 10.1016/S0360-3016(96)00619-0 Lange, 1990, Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. A 5-year experience, Cancer Chemother Pharmacol, 26, S78, 10.1007/BF00685428 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors (Special article), J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 Prentice, 1991, Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses, Biometrics, 47, 825, 10.2307/2532642 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Cox, 1981, Causes of treatment failure and death in carcinoma of the lung, Yale J Biol Med, 54, 201 Hryniuk, 1990, The calculation of received dose intensity, J Clin Oncol, 8, 1935, 10.1200/JCO.1990.8.12.1935 Pujol, 2006, Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials, Lung Cancer, 51, 335, 10.1016/j.lungcan.2005.11.001 Nieder, 2006, Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors, Radiat Oncol, 27, 1 Kim, 2005, Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer, Oncol Rep, 14, 207 Cortes, 2003, Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer, Oncology, 64, 28, 10.1159/000066520 Bernardo, 2002, First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study, Cancer Invest, 20, 293, 10.1081/CNV-120001173 Johnson, 1996, Ifosfamide in non-small-cell lung cancer, Semin Oncol, 23, 7 Creaven, 1974, Clinical pharmacology of ifosfamide, Clin Pharmacol Ther, 16, 77, 10.1002/cpt1974161part177 Elias, 1990, High-dose ifosfamide with mesna uroprotection: a phase I study, J Clin Oncol, 8, 170, 10.1200/JCO.1990.8.1.170 Hartmann, 2007, Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group, J Clin Oncol, 25, 5742, 10.1200/JCO.2007.11.9099 Delbaldo, 2007, Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD004569.pub2 Le Chevalier, 1994, Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients, J Clin Oncol, 12, 360, 10.1200/JCO.1994.12.2.360